Seroprevalence of HIV and Hepatitis B Virus Infection and Related Risk Factors Among Injection Drug Users in Kashan

Background: Drug injection is one of the most important risk factor for human immunodeficiency virus (HIV) and viral hepatitis B virus (HBV) infection. The present study was performed to evaluate the seroprevalence of HBV and HIV infection among injecting drug users (IDUs) and to identify the relate...

Full description

Bibliographic Details
Main Authors: M. Moamen Heravi, H. Afzali, R. Razaghi, Z. Vakili
Format: Article
Language:fas
Published: Alborz University of Medical Sciencs 2013-08-01
Series:Bihdād
Subjects:
Online Access:http://aums.abzums.ac.ir/browse.php?a_code=A-10-1-56&slc_lang=en&sid=1
_version_ 1811242884767154176
author M. Moamen Heravi
H. Afzali
R. Razaghi
Z. Vakili
author_facet M. Moamen Heravi
H. Afzali
R. Razaghi
Z. Vakili
author_sort M. Moamen Heravi
collection DOAJ
description Background: Drug injection is one of the most important risk factor for human immunodeficiency virus (HIV) and viral hepatitis B virus (HBV) infection. The present study was performed to evaluate the seroprevalence of HBV and HIV infection among injecting drug users (IDUs) and to identify the related risk factors for these infections in this group. Methods: This descriptive-analytical study was carried out on three hundred IDUs coming to MMT, DIC and behavior counseling centers in kashan in 2009. questionnaires consisting of demographic information and related risk factors of HBV, HIV infection were filled through interviews. After taking consent , 5 cc blood were obtained. HBV and HIV infection using enzyme-linked immunosorbent assay(ELISA) were examined HIV positive cases were confirmed by western blot. Data analyzed using Spss (version 16). and K square and fisher exat test. Results: 288(96%) out of 300 IDUs, were male and 12(4%)were female. The majority of IDUs 127(42. 3%) were in 30-39 age group with mean age 34. 9±9. 7. (Min:17,Max 68). The majority of IDUs 224(74. 7%) had more than 10 years history of addiction .The age range of onset addiction was 15-20 year in the most of cases 134(44. 7%). The prevalence of HIV was 7(2. 3%), and HBsAg+2(0. 7%). There was no coinfection HIV and HBV. Conclusion: According to High risk behaviors in IDUs and identified HIV cases among them, periodic screening of IDU, HBV vaccination and treatment of addiction and development of MMT centers to prevent of these infections is recommended.
first_indexed 2024-04-12T13:57:43Z
format Article
id doaj.art-41c362be83b64bf581be3e2a3c2b578f
institution Directory Open Access Journal
issn 1735-6679
language fas
last_indexed 2024-04-12T13:57:43Z
publishDate 2013-08-01
publisher Alborz University of Medical Sciencs
record_format Article
series Bihdād
spelling doaj.art-41c362be83b64bf581be3e2a3c2b578f2022-12-22T03:30:18ZfasAlborz University of Medical SciencsBihdād1735-66792013-08-0123156162Seroprevalence of HIV and Hepatitis B Virus Infection and Related Risk Factors Among Injection Drug Users in KashanM. Moamen Heravi0H. Afzali1R. Razaghi2Z. Vakili3 Department of Infectious Diseases, Kashan University of Medical Sciences, Kashan, Iran Department of Infectious Diseases, Kashan University of Medical Sciences, Kashan, Iran Department of Pathology, Kashan University of Medical Sciences, Kashan, Iran Department of Infectious Diseases, Kashan University of Medical Sciences, Kashan, Iran Background: Drug injection is one of the most important risk factor for human immunodeficiency virus (HIV) and viral hepatitis B virus (HBV) infection. The present study was performed to evaluate the seroprevalence of HBV and HIV infection among injecting drug users (IDUs) and to identify the related risk factors for these infections in this group. Methods: This descriptive-analytical study was carried out on three hundred IDUs coming to MMT, DIC and behavior counseling centers in kashan in 2009. questionnaires consisting of demographic information and related risk factors of HBV, HIV infection were filled through interviews. After taking consent , 5 cc blood were obtained. HBV and HIV infection using enzyme-linked immunosorbent assay(ELISA) were examined HIV positive cases were confirmed by western blot. Data analyzed using Spss (version 16). and K square and fisher exat test. Results: 288(96%) out of 300 IDUs, were male and 12(4%)were female. The majority of IDUs 127(42. 3%) were in 30-39 age group with mean age 34. 9±9. 7. (Min:17,Max 68). The majority of IDUs 224(74. 7%) had more than 10 years history of addiction .The age range of onset addiction was 15-20 year in the most of cases 134(44. 7%). The prevalence of HIV was 7(2. 3%), and HBsAg+2(0. 7%). There was no coinfection HIV and HBV. Conclusion: According to High risk behaviors in IDUs and identified HIV cases among them, periodic screening of IDU, HBV vaccination and treatment of addiction and development of MMT centers to prevent of these infections is recommended.http://aums.abzums.ac.ir/browse.php?a_code=A-10-1-56&slc_lang=en&sid=1Seroprevalence risk factors HIV HBV
spellingShingle M. Moamen Heravi
H. Afzali
R. Razaghi
Z. Vakili
Seroprevalence of HIV and Hepatitis B Virus Infection and Related Risk Factors Among Injection Drug Users in Kashan
Bihdād
Seroprevalence
risk factors
HIV
HBV
title Seroprevalence of HIV and Hepatitis B Virus Infection and Related Risk Factors Among Injection Drug Users in Kashan
title_full Seroprevalence of HIV and Hepatitis B Virus Infection and Related Risk Factors Among Injection Drug Users in Kashan
title_fullStr Seroprevalence of HIV and Hepatitis B Virus Infection and Related Risk Factors Among Injection Drug Users in Kashan
title_full_unstemmed Seroprevalence of HIV and Hepatitis B Virus Infection and Related Risk Factors Among Injection Drug Users in Kashan
title_short Seroprevalence of HIV and Hepatitis B Virus Infection and Related Risk Factors Among Injection Drug Users in Kashan
title_sort seroprevalence of hiv and hepatitis b virus infection and related risk factors among injection drug users in kashan
topic Seroprevalence
risk factors
HIV
HBV
url http://aums.abzums.ac.ir/browse.php?a_code=A-10-1-56&slc_lang=en&sid=1
work_keys_str_mv AT mmoamenheravi seroprevalenceofhivandhepatitisbvirusinfectionandrelatedriskfactorsamonginjectiondrugusersinkashan
AT hafzali seroprevalenceofhivandhepatitisbvirusinfectionandrelatedriskfactorsamonginjectiondrugusersinkashan
AT rrazaghi seroprevalenceofhivandhepatitisbvirusinfectionandrelatedriskfactorsamonginjectiondrugusersinkashan
AT zvakili seroprevalenceofhivandhepatitisbvirusinfectionandrelatedriskfactorsamonginjectiondrugusersinkashan